DivestmentApr 30, 2026, 04:48 PM
PRGO Completes Dermacosmetics Divestment for €305.6M Upfront
AI Summary
Perrigo Company plc completed the sale of its Dermacosmetics branded business to Karo Healthcare for an upfront cash payment of €305.6 million. The transaction also includes potential contingent consideration of up to €27.0 million based on future performance. This divestment aligns with Perrigo's "Three-S plan" to streamline its portfolio, enhance financial flexibility, and reduce debt.
Key Highlights
- Completed divestment of Dermacosmetics business to Karo Healthcare.
- Received €305.6M upfront cash, including €5.6M working capital adjustments.
- Eligible for up to €27.0M in contingent cash consideration.
- Total transaction consideration up to €332.6M.
- Proceeds primarily for debt reduction.
- Dermacosmetics business generated ~€120M net sales in 2025.
- Represented ~5% of Perrigo's adjusted operating income in 2025.